Loading...
 
Mediterr J Rheumatol 2023;34(3):342-8
Comparison of Risk Factors During First and Second Wave of COVID-19 in Patients with Autoimmune Rheumatic Diseases (AIRD): Results from KRACC Subset
Authors Information

1Clinical Immunology, Bhagwan Mahaveer Jain Hospital, Bengaluru, Karnataka, India

2Department of Clinical Immunology and Rheumatology, St. John's Medical College Hospital, Bengaluru, Karnataka, India

3Department of Rheumatology, Optima Arthritis and Rheumatology Clinic, Bengaluru, Karnataka, India

4Division of Epidemiology and Biostatistics, St. John’s Research Institute, St. John's Medical College Hospital, Bengaluru, Karnataka, India

V Jain, V Shobha, S Kumar, R Janardana, S Selvam 

References
  1. Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C, et al. Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France. Lancet Reg Heal - Eur 2022 Feb 1;13:100278.
  2. Thiruvengadam R, Awasthi A, Medigeshi G, Bhattacharya S, Mani S, Sivasubbu S, et al. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses. Lancet Infect Dis 2022 Apr;22(4):473-82.
  3. Yang W, Shaman J. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. J R Soc Interface 2022 Jun; 19(191):20210900.
  4. Gianfrancesco M, Hyrich KL, Hyrich KL, Al-Adely S, Al-Adely S, Carmona L, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2020 Jul 1;79(7):859-66.
  5. Xu C, Yi Z, Cai R, Chen R, Thong BYH, Mu R. Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data. Autoimmun Rev 2021 Apr 1;20(4):102778.
  6. Marques CDL, Kakehasi AM, Pinheiro MM, Mota LMH, Albuquerque CP, Silva CR, et al. Original research: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open 2021 Jan 28;7(1):1461.
  7. Shobha V, Chanakya K, Haridas V, Kumar S, Chebbi P, Pinto B, et al. Do all patients with rheumatic Diseases have a higher risk of COVID 19? Initial results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16(2):164.
  8. Patil A, Chanakya K, Shenoy P, Chandrashekara S, Haridas V, Kumar S, et al. A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic Diseases. BMC Rheumatol 2022 June 14;6:32. https://doi.org/10.1186/s41927-022-00264-0.
  9. Rentsch CT, DeVito NJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, et al. Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. Lancet Rheumatol 2021 Jan 1;3(1):e19.
  10. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2021 Jul 1;80(7):930-42.
  11. Fasano S, Pantano I, Mauro D, Capocotta D, Iacono D, Gaggiano E, et al. POS1210 Prevalence of Covid-19 Among Patients with Rheumatic Diseases: An Observational Survey During the Two Waves in Italy. Ann Rheum Dis 2021 Jun 1;80(Suppl 1):888.
  12. Reddy MM, Zaman K, Mishra SK, Yadav P, Kant R. Differences in age distribution in first and second waves of COVID-19 in eastern Uttar Pradesh, India. Diabetes Metab Syndr 2021 Nov 1;15(6):102327.
  13. Schälter F, Dürholz K, Bucci L, Burmester G, Caporali R, Figuereido C, et al. Does methotrexate influence COVID-19 infection? Case series and mechanistic data. Arthritis Res Ther 2021 Dec 1;23(1):166.
  14. Kerai S, Singh R, Dutta S, Mahajan A, Agarwal M. Comparison of Clinical    Characteristics and Outcome of Critically Ill Patients Admitted to Tertiary Care Intensive Care Units in India during the Peak Months of First and Second Waves of COVID-19 Pandemic: A Retrospective Analysis. Indian J Crit Care Med 2021 Dec 1;25(12):1349.
  15. Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol 2022 Apr;18(4):191-204.